/ /

  • linkedin
  • Increase Font
  • Sharebar

    Haze after PRK, LASIK tied to faulty epithelial regrowth

    Improper laser maintenance may likely hinder basement membrane regeneration


    Lasers producing more stromal surface irregularity are associated with higher incidence of severe haze, and haze at lower levels of correction.

    “In these situations, there is a mechanical impediment to the basement membrane healing,” he said. “Poorly maintained excimer lasers are more likely to produce such irregularities.”

    Haze can occur after infection as well, he said, citing a pseudomonas rabbit model in which defects in the epithelial basement membrane led to the development of fibrosis.

    The epithelial basement membrane slowly regenerates in many corneas with severe haze, causing localized myofibrobast apoptosis and reabsorption of abnormal extracelluar matrix by the repopulating keratocytes. The keratocytes form lacunae which coalesce in a clear cornea.

    Mytomycin C can prevent haze after PRK by inhibiting proliferation of myofibroblast precursors.

    Haze developing despite retreatment--“breakthrough haze”--is less likely to resolve over time, probably due to a prolonged decrease in normal anterior keratocyte density or altered keratocyte function.

    Breakthrough haze is more common in humans with a 0.01% concentration than with a 0.02% concentration of mytomycin C.

    In most eyes, transient early mild haze following PRK is caused by corneal fibroblasts, not myofibroblasts. In rabbits, haze can be associated with fibroblasts in normal riboflavin-UV cross-linking and with RK or AK incisions.

    A future gene therapy may transiently express components--such as nidogen-1 and nidogen-2, perlecan, or laminin alpha-3-- which would be provided by keratocytes to regenerate the basement membrane, he predicted.


    Steven E. Wilson, MD

    E: [email protected]

    This article was adapted from a presentation presented at the Refractive Surgery Subpecialty Day during the 2016 American Academy of Ophthalmology meeting. Dr. Wilson is a consultant to Allergan, Cambium Medical Technologies, and Seattle Genetics.

    New Call-to-action


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available


    View Results